Close to 130 industry and non-industry players, across the globe>>

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.
 
To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this link
 
The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:
Target Disease Indication
  • Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Lupus Nephritis
  • Melanoma
  • Multiple Myeloma
  • Primary Sjögren's Syndrome
  • Others
Target Immune Checkpoint
  • B7-H3
  • CD38
  • CD40
  • CD47
  • Others
Mechanism of Action
  • Inhibitory
  • Stimulatory
Therapeutic Modality
  • Monoclonal Antibody
  • Small Molecule
Type of Therapy
  • Monotherapy
  • Combination Therapy
Route of Administration
  • Intravenous
  • Subcutaneous
  • Others
Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific and the Rest of the World
 
The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 
  • Advanced Accelerator Applications
  • Belgian Nuclear Research Center (SCK•CEN)
  • Cardinal Health
  • China Isotope & Radiation Corporation
  • Curium Pharma
  • DuChemBio
  • Eckert & Ziegler
  • Eczacibasi-Monrol
  • GE Healthcare
  • Jubilant DraxImage
  • Lantheus Medical Imaging
  • Nihon Medi-Physics
  • Nordion
  • PETNET Solutions
  • SinoTau Pharmaceuticals
  • SOFIE
 
Table of Contents
 
1. Preface

2. Executive Summary

3. Introduction


4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape


5. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape


6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America


7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe


8. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World


9. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis


10. Partnerships and Collaborations


11. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)


12. Market Forecast and Opportunity Analysis


13. Concluding Remarks
14. Executive Insights
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies and Organizations
 
To purchase a copy, please visit https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]  

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
747 Posts

Made with by Mamby